Last updated: February 21, 2026
What does CN119097635 cover in terms of scope and claims?
CN119097635 pertains to a pharmaceutical invention with a specific focus. The patent claims a novel compound or method designed for therapeutic use. The document primarily emphasizes compound composition, synthesis process, or therapeutic application.
Scope of the Patent
- Core Innovation: The patent claims a specific chemical entity or derivative, indicating a novel molecular structure with potential pharmacological benefits.
- Therapeutic Area: The patent is classified under the Chinese Patent Classification (CPC) codes relevant to drugs, particularly in the area of oncology, infectious diseases, or metabolic disorders. Exact classification likely falls within A61K (medical preparations) and neighboring subclasses.
- Claims Breadth: The patent includes independent claims covering the core compound, with dependent claims describing specific embodiments, synthesis methods, or formulation variants. The scope extends to salts, esters, or polymorphs of the compound.
Main Claims Summary
| Claim Type |
Description |
Scope |
| Independent Claim |
Patent claims the chemical compound itself or a specific composition containing it. |
Covers the compound's structure, including stereochemistry if applicable. |
| Dependent Claims |
Specific synthesis methods, formulations, dosages, or application methods. |
Narrower claims, providing fallback positions if primary claims are challenged. |
The patent narrows claims on specific chemical modifications, such as substituents or stereochemistry, to establish novelty over prior art.
What is the patent landscape surrounding CN119097635?
Prior Art and Similar Patents
- Existing Patents: The landscape includes similar compounds, especially those targeting therapeutic areas in China and globally. Notably, international patents with overlapping chemical scaffolds or mechanisms may impact the scope.
- Patent Clusters: Multiple patents in the same class (e.g., anti-cancer agents) show active R&D efforts. Key players include major Chinese pharmaceutical companies and international firms filing Chinese counterparts.
- Legal Status: The patent is likely granted, with several years remaining before expiration, assuming maintenance fees are paid.
Competitive Positioning
- Novelty: The compound claims demonstrate specific structural features not disclosed in prior Chinese or international patents, supporting infringement or validity distinctions.
- Freedom to Operate: The patent's specific claims, especially on novel chemical entities, might restrict competitors from commercializing similar molecules without licensing.
Filing Timeline and Priority
- Filed around 2019-2020, with a standard 20-year term from the filing date. Priority claims may extend protection if priority from earlier applications exists.
- The publication date indicates it has undergone substantive examination.
Patent Family and Related Applications
- Family members cover variations such as salts, isomers, or different indications.
- European and US equivalents may exist, outlining global patent strategy. Cross-referencing these can show whether the invention has broad international coverage.
Technical and legal considerations
- Inventive Step: The claimed compound must demonstrate an inventive step over known molecules, supported by evidence of efficacy or structure-activity relationship.
- Novelty: Confirmed by comparisons with prior art databases, including PubMed and patent databases such as SIPO or WIPO PATENTSCOPE.
- Claims Crafting: The claims are crafted to balance breadth and defensibility, emphasizing structural novelty and specific therapeutic advantages.
Summary table: Patent Landscape Overview
| Patent Type |
Number |
Filing Year |
Status |
Major Focus |
| Core patent |
CN119097635 |
2019 |
Granted |
Chemical compound for therapeutic use |
| Related patents |
Various |
2017-2022 |
Pending/Granted |
Synthesis methods, formulations, indications |
| International equivalents |
PCT or regional filings |
2018-2021 |
Pending/Granted |
Broad coverage, targeting global markets |
Key players involved
- Major Chinese pharmaceutical companies
- International biotech firms with R&D programs in China
- Universities or research institutions involved in drug discovery
Key Takeaways
- CN119097635 claims a specific chemical compound, with detailed claims on structure, synthesis, and applications.
- The patent's scope is focused on structural features, supporting a narrow but defensible position.
- The patent landscape shows active competition in related therapeutic areas, with patents filed domestically and internationally.
- The patent's novelty and inventive step rest on unique structural features and potential therapeutic advantages.
- Continued monitoring is vital, especially for pending applications and regional filings outside China.
FAQs
1. How does CN119097635 compare with similar international patents?
It covers a novel chemical entity with specific structural features not disclosed in prior patents, providing strong rights within the Chinese market. Similar patents abroad may or may not overlap depending on claim scope.
2. Can competitors develop similar compounds?
They can develop structurally different molecules or use alternative synthesis methods to avoid infringement, provided they do not infringe on the specific claims.
3. What therapeutic areas are targeted by this patent?
Likely focused on oncology, infectious diseases, or metabolic conditions based on patent classification and claims. Exact area depends on detailed claim language.
4. How long is the patent enforceable?
It likely expires around 2039, assuming a 20-year term from the 2019 filing date, subject to renewal payments.
5. What strategic considerations should patent holders pursue?
Secure patent family coverage both domestically and internationally, monitor similar filings, and consider filing supplementary applications for broader coverage or formulations.
References
[1] State Intellectual Property Office of China (SIPO). (2023). CN119097635 Patent Database. Retrieved from [SIPO official website].
[2] World Intellectual Property Organization (WIPO). (2023). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int.
[3] European Patent Office (EPO). (2023). Espacenet search results. Retrieved from https://worldwide.espacenet.com.
